Comparison of breast cancer mortality rates with those of ovarian and colorectal carcinoma
- PMID: 17377931
- DOI: 10.1002/bjs.5667
Comparison of breast cancer mortality rates with those of ovarian and colorectal carcinoma
Abstract
Background: Traditional survival curves cannot easily be used to predict outcome for an individual patient on a year-to-year basis. This difficulty is partly overcome by yearly mortality analysis. This method was employed to analyse long-term follow-up of three cancers: colorectal, ovarian and breast cancer.
Methods: The study used prospectively collected cancer registry data from geographically defined regions in Scotland. Cohort sizes were 7196 patients with breast cancer, 3200 with colorectal cancer and 1866 with ovarian cancer. Follow-up extended to 23 years.
Results: Two distinct patterns of mortality emerged. Mortality rates for ovarian and colorectal cancer were initially high (41 and 21 per cent) but decreased rapidly; by 10 years patients had either died or were cured. The influence of stage diminished with follow-up. Breast cancer mortality was lower than that of colorectal or ovarian cancer, but remained raised in comparison to the general population throughout follow-up. The influence of breast cancer size reduced with follow-up, whereas that of nodal status persisted.
Conclusion: Patients with breast cancer live at increased risk of death to the end of follow-up, supporting the concept of dormancy in breast cancer biology. This was not observed with colorectal or ovarian cancer.
Copyright (c) 2007 British Journal of Surgery Society Ltd.
Similar articles
-
Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?Cancer. 2008 May 15;112(10):2289-300. doi: 10.1002/cncr.23425. Cancer. 2008. PMID: 18393325
-
Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.J Natl Cancer Inst. 2008 Mar 19;100(6):399-406. doi: 10.1093/jnci/djn033. Epub 2008 Mar 11. J Natl Cancer Inst. 2008. PMID: 18334710
-
Changes in diet and mortality from selected cancers in southern Mediterranean countries, 1960-1989.Eur J Clin Nutr. 1993 Sep;47 Suppl 1:S25-34. Eur J Clin Nutr. 1993. PMID: 8269895 Review.
-
Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.Acta Obstet Gynecol Scand. 2008;87(12):1343-52. doi: 10.1080/00016340802495491. Acta Obstet Gynecol Scand. 2008. PMID: 18951208
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
Cited by
-
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.Cancer Cell. 2011 Dec 13;20(6):701-14. doi: 10.1016/j.ccr.2011.11.002. Epub 2011 Dec 1. Cancer Cell. 2011. PMID: 22137794 Free PMC article.
-
New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.Int J Environ Res Public Health. 2009 Jan;6(1):329-48. doi: 10.3390/ijerph6010347. Epub 2009 Jan 20. Int J Environ Res Public Health. 2009. PMID: 19440287 Free PMC article.
-
Multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation.Cancers (Basel). 2014 Nov 27;6(4):2343-55. doi: 10.3390/cancers6042343. Cancers (Basel). 2014. PMID: 25437254 Free PMC article.
-
Rethinking the metastatic cascade as a therapeutic target.Nat Rev Clin Oncol. 2011 Jun;8(6):325-32. doi: 10.1038/nrclinonc.2011.59. Epub 2011 Apr 19. Nat Rev Clin Oncol. 2011. PMID: 21502993 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical